Demedicalizing Long-Acting PrEP/ART, Rupa Patel, MD, MPH

APACC 2023

Pay-It-Forward HPV Vaccination: A Cost-Effectiveness Analysis, Dan Wu, PhD, MSc, MBBS

APACC 2023

Use Implementation Science to promote best practices in HIV/AIDS Care, Dong (Roman) Xu, PhD, MPP

APACC 2023

Paving the Way to HBV Elimination with Old Stones - Vaccines and PrEP, Yi-Chia Huang, MD

APACC 2023

HPV, HIV, and Cervical cancer prevention, Adeeba Kamarulzaman, MBBS, FRACP, FAMM, FASc HonLLD Monash, DPMP

APACC 2023

The Case for Sex Worker Inclusion in Policy-making: Lessons from Collaborative Research with the Philippine Sex Workers Collective, Sharmila Parmanand, PhD

APACC 2023

On the Pathway to HBV Cure: Challenges and Successes, Seng Gee Lim, FRACP, FRCP, FAMS, MD

APACC 2023

HPV, HIV, and Anal Cancer Prevention, Nittaya Phanuphak, MD, PhD

APACC 2023

Transgender Preferences Related to Long-Acting ART, Jakkrapatara Boonruang, MD

APACC 2023

Clinical Perspective on Long-Acting ART, Stephane Wen-Wei Ku, MD

APACC 2023

WHO Long-Acting Guidelines in Asia, Heather-Marie Schmidt, BMedSc (Hon), MPH, PhD

APACC 2023

Drug Resistant Tuberculosis - Is the Era of Personalised Cocktails Over and Do We Now Have a Single Preferred Regimen? Erlina Burhan, MD, MSc, PhD

APACC 2023

Preventing Death, Hospitalization, and Long COVID-19 – New Evidence from Clinical Trial Data, David Boulware, MD, MPH, CTropMed, FIDSA

APACC 2023

Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore, Barnaby Edward Young, MB BChir, PhD

APACC 2023

Drug Resistant Tuberculosis - Is the Era of Personalised Cocktails Over and Do We Now Have a Single Preferred Regimen?, Erlina Burhan, MD, MSc, PhD

APACC 2023

How to Reduce OIs and AIDS Deaths in Southeast Asia from the WHO, Nathan Ford, MPH, PhD, FRCPE

APACC 2023

Characteristics of Hospitalized COVID-19 Patients in Japan: The Insights From COVID-19 Registry Japan, Kayoko Hayakawa, MD, PhD

APACC 2023

Pietro Lampertico | Current & Future HBV Management and Cure

European Meeting on HIV & Hepatitis 2023

Cepheid - Perspectives on Overcoming the Roadblocks | Christophe Martinaud

International Viral Hepatitis Elimination Meeting (IVHEM) 2022

Roche Diagnostics - Perspectives on Overcoming the Roadblocks | Benjamin LaBrot & Tommy Good

International Viral Hepatitis Elimination Meeting (IVHEM) 2022

Progress Towards Hepatitis Elimination: WHO Perspective | Olufunmilayo Lesi

International Viral Hepatitis Elimination Meeting (IVHEM) 2022

Treatment: Do we need new DAAs, new (long-acting) formulations, and simplification? | Sunil Solomon

International Viral Hepatitis Elimination Meeting (IVHEM) 2022

Treatment Challenges of HBV HBeAg Negative Patients | Marcelo Silva

International Viral Hepatitis Elimination Meeting (IVHEM) 2022

Hepatitis Zero Program in Brazil and Africa | Humberto Silva

International Viral Hepatitis Elimination Meeting (IVHEM) 2022